Singapore: Australia's Anteo Diagnostics has inked a partnership deal with Sigma-Aldrich, a leading supplier of lifescie...
Singapore: Phosphagenics has announced that it has completed enrolment for a phase II trial of an acne treatment candida...
Singapore: Australian immuno-oncology company, Minomic International, is set to launch the first human study of its nove...
Singapore: Australian infectious disease therapy and vaccine development company, BioDiem, has received allowance of Jap...
Singapore: A new drug discovered by researchers' from the University of South Australia and the Third Military Medical U...
Singapore: Though vaccination is considered the most important procedure for healthcare and disease management, it is n...
Singapore: Australian biopharmaceutical company, Specialised Therapeutics Australia (STA), has partnered with European...
Singapore: Australia based Prana Biotechnology has recieved positive opinion from European Medicines Agency's Committee ...
Singapore: Phylogica has engaged Griffin Securities, a specialty investment bank located in New York City, to conduct a ...
Singapore: A single vaccine that immunizes against all types of influenza may soon be a reality, after a team of scienti...
Singapore: Advanced wound care and modern wound closure products are gaining an edge over traditional wound dressings in...
Singapore: US drug giant Hospira recently announced that the biosimilar Inflectra (infliximab) has been registered as a ...
Singapore: GlaxoSmithKline (GSK) and Sun Pharmaceutical announced that their respective wholly owned subsidiaries have r...
Singapore: Australian biotechnology company, Novogen's lead candidate product, TRXE-009, has shown a positive result in ...
Singapore: US-based Amneal pharmaceuticals announced the acquisition of Actavis pharmaceuticals' generic business in Aus...
Singapore: ANI Pharmaceuticals, a global specialty pharmaceutical company recently announced collaboration with IDT Aust...
Singapore: Novartis has announced that it has entered into an agreement to acquire Spinifex Pharmaceuticals, a US and Au...
Singapore: CSL, AustraliaChairman: Professor John ShineRevenue: $6407.8 mnBusiness: Developer and manufacturer of vac...
